No Japanese Enrolled, but AstraZeneca to Discuss Lynparza’s Pancreatic Cancer Data with PMDA: Oncology Chief

David Fredrickson, EVP and President, Oncology Business, AstraZeneca, Meets Press at 2019 ASCO Conference in Chicago AstraZeneca made a splash with its stellar pancreatic data for the PARP inhibitor Lynparza (olaparib) at the year’s largest cancer confab on June 2,...read more